Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study - Scorecard - MDSpire

Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study

  • By

  • Yutaka Sugawara

  • Momoko Kobayashi

  • Eri Mannoji

  • Tomoya Saika

  • Yuki Kado

  • Michiko Yamazaki

  • Tohru Takebe

  • Hajime Higuchi

  • June 8, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of Weekly Symptom Tracking via Patients' Smartphones in Outpatient Cancer Chemotherapy: Insights from the SMART-PRO Study

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationOutpatients receiving chemotherapy
Care Setting

Key Highlights

  • remove

Guideline-Based Recommendations

Diagnosis

    Management

    • R
    • e
    • m
    • o
    • v
    • e
    • u
    • n
    • s
    • u
    • p
    • p
    • o
    • r
    • t
    • e
    • d
    • m
    • a
    • n
    • a
    • g
    • e
    • m
    • e
    • n
    • t
    • r
    • e
    • c
    • o
    • m
    • m
    • e
    • n
    • d
    • a
    • t
    • i
    • o
    • n
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Outpatients aged ≥20 years receiving anticancer chemotherapy

        Patients used their own smartphones to report symptoms weekly

        Clinical Best Practices

        • remove

        Related Resources & Content

        Original Source(s)

        Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study

        • by Yutaka Sugawara, Momoko Kobayashi, Eri Mannoji, Tomoya Saika, Yuki Kado, Michiko Yamazaki, Tohru Takebe, Hajime Higuchi

        • June 8, 2026

        Related Content

        Rearming mesenchymal stem cells with engineering strategies to combat cancer

        Integrative oncology: evolution, framework, and future directions

        Recurrent intracranial hemorrhage without brain metastasis after VEGFR TKI rechallenge in metastatic renal cell carcinoma: a case report and literature review